Market access to Asia is a challenge to most of the companies. Regenta supports the global companies to tap into the high growth Asian markets with expertise in regulatory, clinical development and commercialization.

Therapeutic Focus

We focus on the highly prevalent diseases in Asia with huge unmet needs

R&D and Market Access Platforms

Clinical Trial Platform

Regenta Pharmaceuticals has built a comprehensive operating process to

    • develop innovative drugs across all study stages
    • register the products across Asia
    • manage PhV

We have proven experience in managing clinical trials and registering products not only in China but also in other emerging Asian markets that often are neglected by global biopharma companies such as South East Asian markets.

Commercial Platform

Our mission is to commercialize high quality biopharmaceuticals to patients in needs. Regenta Pharmaceuticals has a well-established commercial infrastructure of marketing, sales, market access, channel management, and medical affairs. We have the access to 5,000 hospitals and 90 distributors in Asia.